News

Main > News > 2012

February 2012

02.02 In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival

01.02 Erivedge - Treatment For Most Common Form Of Skin Cancer

01.02 FDA Approves Drug For Common Skin Cancer

01.02 Kalydeco - A Cystic Fibrosis Treatment


Pages 1 2 3



Company’s services

Up to date the Company’s business activities include the functional business blocks.

All services are described in one booklet
Business Ethic Code
Medical device and IVD consulting services Registration and certification of medical products
Cosmetics and parapharmaceutical products Registration and certification of cosmetics and parapharmaceutical products
Pharmaceutical Services in the field of import/export of medicines
Licensing activities and manufacture Licensing of activities in the field of distribution of medical devices and pharmaceutical products
Our company Our services Responsibility News Career Contacts